- Who is Sysmex ?
- Qualité et Développement Durable
- Nouvelles et événements
- Diagnostic In Vitro
- Life Science
- Industry & Research
- Équipement de laboratoire
- Environnement & Sécurité
Select your local website
Each day, over nine thousand people in Europe are newly diagnosed with cancer. The growing understanding of cancer pathophysiology, and the systematic development of diagnostic and therapeutic solutions are leading to improved survival rates and quality of life for many.
To continue this trend, medical disciplines and specialists are merging expertise and experience. They are stronger together.
At Sysmex, we too contribute to improving patient care in cancer management. With profound scientific knowledge and an understanding of clinical needs, we work closely with our partners to deliver innovative diagnostic solutions and therapeutic support that, wherever possible, address patients and their therapy individually.
Through greater efficiency in clinics, diagnostics that take into account patient wellbeing, and by reducing side- and post effects, we’re lighting the way in cancer management.